Aeromics Employee Directory

Aeromics corporate office is located in 470 James St Ste 7, New Haven, Connecticut, 06513, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

2

Operations

1

Finance

1

C-Suite

1

Medical & Health

1

Key Employees of Aeromics

Aeromics Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from Aeromics

Hundreds of professionals searching for Aeromics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Aeromics

Explore people who held key positions, contributed to Aeromics's success, and advanced their careers.

  1. Chief Medical Officer ... at Cognition Therapeutics

    Worked as Interim Chief Medical Officer

    at Aeromics (2018-2019)

    email Anthony Caggiano Email direct Anthony Caggiano Direct
  2. Managing Principal at Riverfront Recapture

    Worked as Chief Financial Officer

    at Aeromics (2016-2019)

    email Christine Antalik Email direct Christine Antalik Direct
  3. Research 4 Assistant at Case Western Reserve U...

    Worked as Senior Research Scientist

    at Aeromics (2011-2017)

    email Susan Farr Email direct Susan Farr Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Connecticut, United States

Frequently Asked Questions Regarding Aeromics Employees

How many employees does Aeromics have?
Aeromics has 1-10 employees
Who are Aeromics key employees?
Some of Aeromics key employees are Trevor Thompson
Where is Aeromics located?
Aeromics’s headquarters are located at 470 James St Ste 7, New Haven, Connecticut, 06513, United States
How do I contact Aeromics?
Aeromics Contact Info: Phone number: (203) 208-8864 Website: www.aeromics.com
What does Aeromics do?

Aeromics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapeutics targeting aquaporin-4 (AQP4) to control edema in patients suffering from severe ischemic stroke and other conditions. Their lead product, AER-271, aims to prevent brain swelling following ischemic events, significantly improving patient outcomes... and recovery times. The company is currently conducting Phase 1 clinical trials to assess the safety and tolerability of AER-271, with plans for a Phase II efficacy trial. Aeromics is dedicated to addressing critical medical needs in neurology through advanced understanding of water physiology.Read More

Is Aeromics a public company?
Aeromics is private company therefore does not currently have an official ticker symbol
See more information about Aeromics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.